MedTrace Logo

Pre-treatment With Methylene Blue Prevent Peri-operative Reduced Systemic Vascular Resistance

NCT03406676 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-01-23

No results posted yet for this study

Summary

To explore the effects of pre-treatment with methylene blue on reduced perioperative vascular resistance in patients with obstructive jaundice.

Conditions

  • Obstructive Jaundice

Interventions

DRUG

Methylene Blue

2mg / Kg of methylene blue in volume of 50ml is administrated I.V before anesthesia induction.

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Principal Investigators

  • Zheng ShuGuo · MD Study Director Institute of Hepatobiliary Surgery ,Southwest Hospital ,Third Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-10-30
Completion
2018-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03406676 on ClinicalTrials.gov